Publicaciones en las que colabora con ANA MARIA GONZALEZ PINTO ARRILLAGA (11)

2021

  1. A multicentre, randomised, controlled trial of a combined clinical treatment for first-episode psychosis

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 14

2016

  1. BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year

    Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151

2015

  1. Subclinical depressive symptoms and continued cannabis use: Predictors of negative outcomes in first episode psychosis

    PLoS ONE, Vol. 10, Núm. 4

2014

  1. Novel association of Neuregulin 1 gene with bipolar disorder but not with schizophrenia

    Schizophrenia Research

2013

  1. Plasma brain-derived neurotrophic factor levels, learning capacity and cognition in patients with first episode psychosis

    BMC Psychiatry, Vol. 13

  2. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 44, pp. 29-33

2012

  1. Serum IgG antibodies against the NR1 subunit of the NMDA Receptor not detected in schizophrenia

    American Journal of Psychiatry

2010

  1. Expression of oligodendrocyte and myelin genes is not altered in peripheral blood cells of patients with first-episode schizophrenia and bipolar disorder

    Bipolar Disorders

  2. Increase in brain-derived neurotrophic factor in first episode psychotic patients after treatment with atypical antipsychotics

    International Clinical Psychopharmacology, Vol. 25, Núm. 4, pp. 241-245

2007

  1. Decreased levels of plasma glutamate in patients with first-episode schizophrenia and bipolar disorder

    Schizophrenia Research, Vol. 95, Núm. 1-3, pp. 174-178

2006

  1. Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients

    Schizophrenia Research